Royal Marsden NHS Foundation Trust: all 272 studies

Page 3 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.

• Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerCompletedNCT01216813
• The Use of a Quality of Life Questionnaire in Patients With Lung CancerStatus unknownNCT01213745Not applicable
• Comparison of the Diagnostic Accuracy of 3D Volume Acquisition MRI With CT in Staging Colonic CancerCompletedNCT01187641
• Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal CancerCompletedNCT01170299Not applicable
• Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerStatus unknownNCT01087268Phase 3
• A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)TerminatedNCT01050426Phase 2
• Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic CancerCompletedNCT01048320Phase 1
• Partial Liver Radiotherapy for Unresectable Liver MetastasesStatus unknownNCT01048216Not applicable
• Avoiding Surgery in Rectal Cancer After Pre-Operative TherapyStatus unknownNCT01047969Phase 2
• Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksStatus unknownNCT01037049Phase 2
• Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients SettingCompletedNCT01034696
• Evaluation of Bladder Volumes in Patients Receiving Radiotherapy to the Rectum, Using Kilovoltage Cone-beam ImagingStatus unknownNCT01033682
• The Physiological Response to Routine Head and Neck Cancer SurgeryCompletedNCT01032096
• Analysis of Pharmacodynamic Changes With AUY922A, an HSP90 InhibitorStatus unknownNCT01024283
• Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal CancerCompletedNCT01022541Phase 2
• Patient Satisfaction in the Critical Care Unit: A Qualitative Phenomenological StudyStatus unknownNCT01007162
• Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate CancerStatus unknownNCT01006564Not applicable
• Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung CancerStatus unknownNCT01003522Phase 3
• Novel Prognostic Markers in Renal CancerCompletedNCT01002937
• The Identification of Novel Prognostic Markers in MelanomaStatus unknownNCT01002560
• SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)CompletedNCT01001728Phase 3
• Adaptive Planning in Bladder CancerStatus unknownNCT01000129Phase 2
• An Exploration of Genetic Testing for Prostate Cancer SusceptibilityStatus unknownNCT00997464
• Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH)CompletedNCT00996450
• Methotrexate in Metastatic Colorectal Cancer With MSH2 DeficiencyTerminatedNCT00952016Phase 2
• Intensity-Modulated Radiation Therapy in Treating Patients With Prostate CancerStatus unknownNCT00946543Phase 1
• Measurement of the Folate Receptor in BloodCompletedNCT00838747
• Functional Imaging in HNC Undergoing ChemoradiationStatus unknownNCT00837980
• SS-GCC1- Screening Study of Genetic Changes in Colorectal CancerStatus unknownNCT00825110
• REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG CancerTerminatedNCT00824785Phase 3
• R-CHOP-B Bevacizumab for Diffuse Large B Cell LymphomaTerminatedNCT00788606Phase 2
• FR in Stored PlasmaCompletedNCT00787514
• Radioiodine Dosimetry Protocol for Thyroid Cancer MetastasesStatus unknownNCT00749697Not applicable
• Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the PelvisCompletedNCT00737230Not applicable
• Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the BreastCompletedNCT00602628Not applicable
• Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast CancerStatus unknownNCT00602316Not applicable
• Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular CancerStatus unknownNCT00553371
• Evaluation of Group CBT Programme With Breast Cancer PatientsStatus unknownNCT00426335
• Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerStatus unknownNCT00383695Phase 2
• A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple MyelomaCompletedNCT00323505Phase 2
• A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).CompletedNCT00301314
• A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT00301301
• A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).CompletedNCT00301288
• Assessing Free Immunoglobulin Light Chains in Patients With MyelomaCompletedNCT00301275
• A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.CompletedNCT00300664Phase 2/3
• A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.Status unknownNCT00299351Phase 2
• Modelling Internal Hepatic Movement With an External Abdominal MarkerStatus unknownNCT00299299
• Dual Time Point PET Imaging in LymphomaStatus unknownNCT00297557
• A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 DeletionCompletedNCT00292760Phase 2
• Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic CancerCompletedNCT00260364Phase 1/2
• Prospective Study in Pelvic Radiotherapy PatientsCompletedNCT00220181
• Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI TumoursCompletedNCT00220168Phase 4
• Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal CancerCompletedNCT00220155Phase 2
• Molecular Markers of Prognosis in Colorectal Cancer PatientsCompletedNCT00220142
• Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the OesophagusCompletedNCT00220129Phase 2
• Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal CancerCompletedNCT00220116Phase 2
• Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal AdenocarcinomaCompletedNCT00220103Phase 2
• Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal CancerStatus unknownNCT00220077Not applicable
• A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI TumoursCompletedNCT00220064Phase 2
• A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal CancerCompletedNCT00220051Phase 2
• Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast CancerStatus unknownNCT00083018Phase 2
• Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast CancerStatus unknownNCT00082979Phase 2
• Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced XerostomiaStatus unknownNCT00081029Phase 3
• Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast CancerCompletedNCT00081003Not applicable
• IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast CancerStatus unknownNCT00041223Phase 2
• Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast CancerCompletedNCT00022204Phase 2
• Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast CancerStatus unknownNCT00005821Phase 2
• Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast CancerStatus unknownNCT00005600Not applicable
• Diagnosis and Treatment Planning in Patients Suspected of Having Lung CancerStatus unknownNCT00005071Not applicable
• Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast CancerStatus unknownNCT00005058Not applicable
• Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal CancerCompletedNCT00004256Phase 2
• Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00004237Phase 2

← Royal Marsden NHS Foundation Trust overview and focus areas